
CIPA AAA Demands
In an earlier piece, we discussed the proliferation of California Invasion of Privacy Act (“CIPA”) claims brought in arbitration proceedings. The two largest arbitration forums
B.A. 1985, State University of New York, Binghamton
J.D. 1988, Rutgers University
Sean is admitted to practice in New York and before the U.S. District Court, Southern, Western and Eastern Districts of New York and has litigated in State and Federal Courts, and before regulatory agencies, throughout the U.S.
Sean Moynihan heads up our litigation department. He oversees all of the firm’s civil, commercial and regulatory litigation matters. He has successfully defended dozens of consumer class action matters in the Internet space, as well as scores of regulatory matters around the U.S.
Sean concentrates on litigating Internet, gaming, sweepstakes, gambling law, and intellectual property cases, as well as related regulatory matters. Sean advises clients on all aspects of Internet law, including complex inter-company contracts, online and offline privacy regulations, and FTC regulation.
Prior to joining the firm, Sean was a litigator for several New York City firms. Sean also has been an Adjunct Professor in Advanced Business Law at Dominican College, Blauvelt, NY.
Sean also has extensive experience in complex commercial and business-related litigation. He has litigated a broad range of issues before state and federal courts.
Explore our practice areas to learn how our firm can help ensure your business stays compliant.
Ready for a consultation? Book a free 15 minute call with an attorney.

In an earlier piece, we discussed the proliferation of California Invasion of Privacy Act (“CIPA”) claims brought in arbitration proceedings. The two largest arbitration forums

Our readers shouldn’t mistake our silence for a dearth of Telephone Consumer Protection Act (“TCPA”) quiet hours lawsuits. Last month, The Law Offices of Jibrael

With healthcare open enrollment underway, the Federal Trade Commission (“FTC”) recently issued warning letters to approximately 25 companies that engage in healthcare-related marketing (“Warning Letters”).